Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析

◆英語タイトル:Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1321
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Supernus Pharmaceuticals Inc (SUPN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Supernus Pharmaceuticals Inc (Supernus Pharmaceuticals) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment of partial seizures; and Trokendi XR (topiramate), an initial monotherapy against partial onset or primary generalized tonic-clonic seizures and an adjunct therapy for the treatment of primary generalized tonic-clonic seizures associated with Lennox-Gastaut syndrome. Its also has pipeline products that finds application in the treatment of depression and bipolar depression. The company’s technology platforms include Microtrol (multiparticulate delivery platform), Solutrol (matrix delivery platform) and EnSoTrol (osmotic delivery system). It operates through subsidiary Supernus Europe Ltd. Supernus Pharmaceuticals is headquartered in Rockville, Maryland, the US.

Supernus Pharmaceuticals Inc Key Recent Developments

Mar 30,2020: Supernus provides business update
Feb 26,2020: Supernus to Present at the 2020 Cowen Health Care Conference
Feb 25,2020: Supernus announces fourth quarter and full year 2019 financial results
Nov 11,2019: Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD
Nov 05,2019: Supernus announces third quarter 2019 financial results and topline data from phase III study of SPN-810 for treatment of Impulsive Aggression (IA) in ADHD patients

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Supernus Pharmaceuticals Inc – Key Facts
Supernus Pharmaceuticals Inc – Key Employees
Supernus Pharmaceuticals Inc – Key Employee Biographies
Supernus Pharmaceuticals Inc – Major Products and Services
Supernus Pharmaceuticals Inc – History
Supernus Pharmaceuticals Inc – Company Statement
Supernus Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Supernus Pharmaceuticals Inc – Business Description
Business Segment: Licensing revenue
Performance
Business Segment: Net Product Sales
Performance
Business Segment: Royalty Revenue
Performance
R&D Overview
Supernus Pharmaceuticals Inc – Corporate Strategy
Supernus Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Supernus Pharmaceuticals Inc – Strengths
Supernus Pharmaceuticals Inc – Weaknesses
Supernus Pharmaceuticals Inc – Opportunities
Supernus Pharmaceuticals Inc – Threats
Supernus Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Supernus Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 25, 2020: Supernus announces fourth quarter and full year 2019 financial results
Nov 05, 2019: Supernus announces third quarter 2019 financial results and topline data from phase III study of SPN-810 for treatment of Impulsive Aggression (IA) in ADHD patients
Aug 06, 2019: Supernus announces second quarter 2019 financial results
May 07, 2019: Supernus announces first quarter 2019 financial results
Feb 26, 2019: Supernus announces record full year 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Supernus Pharmaceuticals Inc, Key Facts
Supernus Pharmaceuticals Inc, Key Employees
Supernus Pharmaceuticals Inc, Key Employee Biographies
Supernus Pharmaceuticals Inc, Major Products and Services
Supernus Pharmaceuticals Inc, History
Supernus Pharmaceuticals Inc, Subsidiaries
Supernus Pharmaceuticals Inc, Key Competitors
Supernus Pharmaceuticals Inc, Ratios based on current share price
Supernus Pharmaceuticals Inc, Annual Ratios
Supernus Pharmaceuticals Inc, Annual Ratios (Cont...1)
Supernus Pharmaceuticals Inc, Annual Ratios (Cont...2)
Supernus Pharmaceuticals Inc, Interim Ratios
Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Supernus Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Supernus Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Supernus Pharmaceuticals Inc, Ratio Charts
Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Supernus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Symic Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops new therapeutics focused on matrix biology. The company’s pipeline products include SB-030 and SB-061. Its SB-030 is a clinical candidate used for the prevention of peripheral vascular diseases or vein graft …
  • Marina Portoroz dd:企業の戦略・SWOT・財務分析
    Marina Portoroz dd - Strategy, SWOT and Corporate Finance Report Summary Marina Portoroz dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Grupo TMM, S.A.B.:企業の戦略・SWOT・財務情報
    Grupo TMM, S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo TMM, S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Imperial Metals Corporation:企業の戦略・SWOT・財務情報
    Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report Summary Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Grupo Aval Acciones Y Valores Sa
    Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Studsvik AB (SVIK):企業の財務・戦略的SWOT分析
    Studsvik AB (SVIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Electricity Generating Authority of Thailand:企業の発電所・SWOT分析2018
    Electricity Generating Authority of Thailand - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Getlink SE:企業の戦略・SWOT・財務分析
    Getlink SE - Strategy, SWOT and Corporate Finance Report Summary Getlink SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • UNeMed Corp-医療機器分野:企業M&A・提携分析
    Summary UNeMed Corp (UneMed), a subsidiary of University of Nebraska Medical Center is a healthcare service provider that offers technology transfer and commercialization services. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup form …
  • British American Tobacco (Malaysia) Berhad:戦略・SWOT・企業財務分析
    British American Tobacco (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GliaCure Inc (GliaCure) is a developer of novel therapies for neurological and neuropsychiatric disorders. The company uses glia as an untapped resource for drug discovery, which controls the brain function in health and disease. It develops small molecule pharmaceuticals for the treatment o …
  • Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of m …
  • HTP Korcula d.d.:企業の戦略・SWOT・財務分析
    HTP Korcula d.d. - Strategy, SWOT and Corporate Finance Report Summary HTP Korcula d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Natural Alternatives International Inc (NAII):企業の財務・戦略的SWOT分析
    Summary Natural Alternatives International Inc (NAI) is a formulator and manufacturer of customized nutritional supplements. The company manufactures and distributes the only patented beta-alanine supplement on the market. It offers services such as science-based product formulation, raw material ac …
  • Shire Plc (SHP):企業の財務・戦略的SWOT分析
    Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Autonomous University of Barcelona:製薬・医療:M&Aディール及び事業提携情報
    Summary Autonomous University of Barcelona (UAB) is a public university that offers education, research and knowledge transfer services. The university provides undergraduate, post graduate, masters, doctorates, and foreign undergraduate programs. It offers educational programs in the areas of arts …
  • Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing a …
  • Novita Healthcare Ltd (NHL):製薬・医療:M&Aディール及び事業提携情報
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • PT Jasa Marga (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • University of Massachusetts Medical School:企業のM&A・事業提携・投資動向
    University of Massachusetts Medical School - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Massachusetts Medical School Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆